This study was designed to investigate the cause of haematuria for patients
that had previously undergone a TURP. One hundred patients were identified
in a walk-in haematuria clinic as having been treated by TURP and were pro
spectively investigated for the cause of bleeding. Prostate regrowth was th
e diagnosis in 63% of cases. A diagnosis of malignancy was made for 23.5% o
f these patients. We have confirmed the hypothesis that for patients who pr
esent with haematuria after a TURP, the prostate is the usual source of ble
eding.